Mespas Tablet is a combination medication containing Dicyclomine 10 mg and Mefenamic Acid 250 mg, primarily indicated for the relief of abdominal pain associated with gastrointestinal spasms and dysmenorrhea. Dicyclomine is an anticholinergic agent that acts as a smooth muscle relaxant, reducing muscle spasms in the gastrointestinal tract by inhibiting the action of acetylcholine on muscarinic receptors. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) that exerts analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. The synergistic action of these two components provides effective relief from cramping pain and inflammation. Mespas Tablet is typically administered orally, with dosage adjusted according to the severity of symptoms and patient response. It is contraindicated in patients with hypersensitivity to either component, peptic ulcer disease, severe renal or hepatic impairment, and certain cardiovascular conditions. Common adverse effects may include dry mouth, dizziness, gastrointestinal discomfort, and nausea. Caution is advised when prescribing to pregnant or lactating women. Mespas Tablet should be used under medical supervision, ensuring appropriate evaluation of patient history and concurrent medications to minimize potential drug interactions and adverse reactions.